Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B
- PMID: 14415
Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B
Abstract
Human fibrinogen was treated at pH 6.0, 7.3 and 9.0 with thrombin, batroxobin (thrombin-like fraction of Bothrops atrox venom) or an extract of the venom from Ancistrodon contortrix contortrix. These three enzymes released the NH2-terminal fibrinopeptides A and B at different rates. Thrombin-free, preactivated factor XIII (factor XIIIa) was added to incubation mixtures to stabilize resulting fibrin(ogen) aggregates. Cross-linking of gamma-chains and the size of covalently linked fibrin-fibrinogen oligomers were studied in an early stage of fibrinopeptide cleavage using polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate. Batroxobin (pH 7.3) and thrombin (pH 6.0) preferentially released fibrinopeptide A, and resulting fibrin aggregates became rapidly insoluble. However, when fibrinopeptide B was removed with the contortrix enzyme, soluble cross-linked oligomers appeared initially. The opaque fibrin clots, produced by thrombin (pH 6.0) or contortrix procoagulant fraction (pH 7.3), were found to be devoid of alpha-polymers even after prolonged incubation with factor XIIIa. Our data suggest that the solubility and opacity of fibrin networks are not primarily related to the type of the cross-link (gamma-gamma versus alpha-alpha interactions).
Similar articles
-
Release of fibrinopeptides by the slow and fast forms of thrombin.Biochemistry. 1996 Apr 9;35(14):4417-26. doi: 10.1021/bi952834d. Biochemistry. 1996. PMID: 8605191
-
Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.Biochim Biophys Acta. 1989 Jan 27;990(1):18-24. doi: 10.1016/s0304-4165(89)80006-6. Biochim Biophys Acta. 1989. PMID: 2914147
-
The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.J Mol Biol. 1993 Jul 5;232(1):285-97. doi: 10.1006/jmbi.1993.1382. J Mol Biol. 1993. PMID: 8331664
-
Markers of fibrinogen derivatives used in clinical investigation.Semin Thromb Hemost. 1985 Apr;11(2):129-32. doi: 10.1055/s-2007-1004369. Semin Thromb Hemost. 1985. PMID: 2412296 Review. No abstract available.
-
The structure and biological features of fibrinogen and fibrin.Ann N Y Acad Sci. 2001;936:11-30. doi: 10.1111/j.1749-6632.2001.tb03491.x. Ann N Y Acad Sci. 2001. PMID: 11460466 Review.
Cited by
-
Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective.Biophys Rev. 2022 Apr 6;14(2):427-461. doi: 10.1007/s12551-022-00950-w. eCollection 2022 Apr. Biophys Rev. 2022. PMID: 35399372 Free PMC article. Review.
-
Molecular interference of fibrin's divalent polymerization mechanism enables modulation of multiscale material properties.Biomaterials. 2015 May;49:27-36. doi: 10.1016/j.biomaterials.2015.01.010. Epub 2015 Feb 11. Biomaterials. 2015. PMID: 25725552 Free PMC article.
-
Clot Structure and Implications for Bleeding and Thrombosis.Semin Thromb Hemost. 2020 Feb;46(1):96-104. doi: 10.1055/s-0039-1696944. Epub 2019 Oct 15. Semin Thromb Hemost. 2020. PMID: 31614389 Free PMC article. Review.
-
Strength, deformability and toughness of uncrosslinked fibrin fibers from theoretical reconstruction of stress-strain curves.Acta Biomater. 2021 Dec;136:327-342. doi: 10.1016/j.actbio.2021.09.050. Epub 2021 Oct 2. Acta Biomater. 2021. PMID: 34606991 Free PMC article.
-
Clots of beta-fibrin. Viscoelastic properties, temperature dependence of elasticity, and interaction with fibrinogen-binding tetrapeptides.Biophys J. 1988 Mar;53(3):311-8. doi: 10.1016/S0006-3495(88)83108-4. Biophys J. 1988. PMID: 3349127 Free PMC article.